Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ye, Qifa
NCT05242757: Clinical Study of MAK Immune Cells in the Treatment of PHC	Recruiting	N/A	12	RoW	Mixed-activated Killer Immune Cells	Zhongnan Hospital	Primary Hepatocellular Carcinoma	03/22	03/22